DOI: 10.54005/geneltip.2004811 ISSN: 2602-3741
Incidental and Non-Incidental Gallbladder Carcinoma: A Retrospective Comparison of Clinicopathological Characteristics and Survival Outcomes
Tugba Gunler, İlknur Küçükosmanoğlu, Yaşar Ünlü, Gürcan Şimşek, Meral Büyükterzi Aim: Incidental gallbladder carcinoma (IGBC) refers to malignancies detected during histopathological examination following cholecystectomy performed for benign indications. Although IGBC is generally diagnosed earlier, its impact on survival remains unclear. We compared the clinicopathological characteristics and overall survival outcomes of patients with IGBC and non-incidental gallbladder carcinoma (NIGBC) and evaluated independent prognostic factors affecting survival.Materials and Methods: A total of 69 patients histopathologically diagnosed with gallbladder carcinoma between January 2008 and December 2019 were retrospectively reviewed. Patients were grouped by mode of diagnosis as IGBC (n=40) or NIGBC (n=29). Clinical, surgical, and histopathological characteristics were compared. Overall survival was analyzed using the Kaplan-Meier method, and prognostic factors were evaluated using univariable and multivariable Cox regression analyses.Results: Among 12,938 cholecystectomies performed during the study period, IGBC was identified in 40 cases (0.31%). The median tumor size was significantly smaller in the IGBC group than in the NIGBC group (19 mm vs. 35 mm, p<0.001). In addition, early pT stage (pT1–2) was significantly more frequent in the IGBC group (p<0.001). Among patients with available pathological nodal assessment, Stage I–II disease was also more frequent in the IGBC group than in the NIGBC group (55.6% vs. 20.7%; p=0.014). The presence of gallstones and the rate of laparoscopic surgery were also significantly higher in the IGBC group (p<0.001 for both). No significant difference in overall survival was observed between the groups (log-rank p=0.589). In the multivariable analysis, age, advanced pT stage, and initial surgical margin positivity were identified as independent factors associated with overall survival. Incidental diagnosis was not significantly associated with overall survival in the multivariable analysis.Conclusions: Although patients with IGBC were diagnosed with smaller tumors and at an earlier pT stage, a statistically significant survival advantage associated with incidental diagnosis was not demonstrated in this cohort. Instead, age, advanced pT stage, and initial surgical margin positivity were significantly associated with overall survival.
More from our Archive
-
DOI: 10.1145/3845995 2026
A Survey of LLM-based Software Repair: Taxonomies, Design Paradigms, and Applications Boyang Yang, Zijian Cai, Fengling Liu, Bach Le, Lingming Zhang, Tegawendé F. Bissyandé, Yang Liu, Haoye Tian
-
DOI: 10.1108/jrim-02-2024-0074 2026
Cutting-edge research in social media and interactive marketing: a
review and research agenda James W Peltier, Andrew J Dahl, Lauren Drury, Tracy Khan
-
DOI: 10.1108/jkm-04-2021-0336 2026
Knowledge hiding – a systematic review and research
agenda Amitabh Anand, Florian Offergelt, Payal Anand
-
DOI: 10.1257/aer.20230448 2026
The Unequal Economic Consequences of Carbon Pricing Diego R. Känzig
-
DOI: 10.1017/awf.2026.10115 2026
Part 1: Assessment of upright restraint of broilers for head-only electrical stunning Troy J. Gibson, Georgina Limon, Shannon Campbell, Natalie Chancellor, Katharine A Fletcher, Paul Berry, Jeff Lines
-
DOI: 10.21468/scipostphyscodeb.86 2026
MadAgents Tilman Plehn, Daniel Schiller, Nikita Schmal
-
DOI: 10.21468/scipostphyscodeb.86-r2.0 2026
Codebase release 2.0 for MadAgents Tilman Plehn, Daniel Schiller, Nikita Schmal
-
DOI: 10.21468/scipostphyscodeb.85 2026
svPITE: A Python package for the state-vector-based probabilistic imaginary-time evolution algorithm Pascal Sievers, Satoshi Ejima
-
DOI: 10.21468/scipostphyscodeb.85-r1.1 2026
Codebase release 1.1 for svPITE Pascal Sievers, Satoshi Ejima
-
DOI: 10.1177/02611929261494117 2026
The World Medical Association’s
Declaration of Helsinki
and
Statement on Animal Use in Biomedical Research
: Why reliable and valid preclinical evidence and Natalie Anderson, Jane Kotzmann, Rachel Smith, Kathrin Herrmann